Published in Epidemiol Infect on August 01, 1990
Human campylobacteriosis in developing countries. Emerg Infect Dis (2002) 3.14
Host-pathogen interactions in Campylobacter infections: the host perspective. Clin Microbiol Rev (2008) 1.76
Immunoglobulin A antibodies directed against Campylobacter jejuni flagellin present in breast-milk. Epidemiol Infect (1994) 0.76
Campylobacter enteritis: a "new" disease. Br Med J (1977) 34.77
Related vibrio in stools. J Pediatr (1973) 12.85
Evidence for protection by breast-feeding against infant deaths from infectious diseases in Brazil. Lancet (1987) 4.01
Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol (1980) 2.92
Studies of breast-feeding and infections. How good is the evidence? JAMA (1986) 2.31
A new selective medium for the isolation of Campylobacter jejuni from human faeces. Eur J Clin Microbiol (1983) 2.03
Campylobacter jejuni-specific serum antibodies are elevated in healthy Bangladeshi children. J Clin Microbiol (1985) 1.67
Prevalence of Campylobacter fetus subsp. jejuni in healthy populations in southern India. J Clin Microbiol (1982) 1.57
Erythromycin-resistant Campylobacter infections in Thailand. Antimicrob Agents Chemother (1987) 1.34
Enterotoxigenic Campylobacter jejuni among children in South India. Lancet (1984) 1.08
The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Infect (2008) 5.98
Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol (1989) 3.73
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet (2003) 3.23
Sexual and reproductive life of women informed of their HIV seropositivity: a prospective cohort study in Burkina Faso. J Acquir Immune Defic Syndr (2001) 2.86
Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics (1999) 2.69
Operational issues in preventing mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire, 1998-99. Bull World Health Organ (2001) 2.33
Prevalence of cutaneous disorders in a population of HIV-infected patients. Southwestern France, 1996. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Arch Dermatol (1998) 2.22
Monitoring selective components of primary health care: methodology and community assessment of vaccination, diarrhoea, and malaria practices in Conakry, Guinea. ACSI-CCCD team. Bull World Health Organ (1989) 2.20
Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet (1993) 2.18
Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. Int J Tuberc Lung Dis (2011) 2.15
Implementing family-focused HIV care and treatment: the first 2 years' experience of the mother-to-child transmission-plus program in Abidjan, Côte d'Ivoire. Trop Med Int Health (2009) 2.07
Effect of gender, age, transmission category, and antiretroviral therapy on the progression of human immunodeficiency virus infection using multistate Markov models. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Epidemiology (1998) 2.00
CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients? J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.99
Cardio- and cerebrovascular events in HIV-infected persons. AIDS (2004) 1.98
Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme. Bull World Health Organ (2009) 1.81
Living with HIV: women's experience in Burkina Faso, West Africa. AIDS Care (2001) 1.73
Loss to follow-up in an international, multicentre observational study. HIV Med (2008) 1.70
A cohort study of factors associated with failure to return for HIV post-test counselling in pregnant women: Kigali, Rwanda, 1992-1993. AIDS (1996) 1.60
Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). Clin Pharmacol Ther (2008) 1.56
Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients. Antimicrob Agents Chemother (2002) 1.54
[Cervicofacial hydatid cyst. Apropos of 9 cases]. Rev Laryngol Otol Rhinol (Bord) (1985) 1.50
Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology. Stat Med (2001) 1.50
Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. HIV Med (2002) 1.44
Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994. Pregnancy and HIV Study Group. AIDS (1998) 1.42
[Seroprevalence of viral hepatitis C in patients with human immunodeficiency virus infection]. Presse Med (1992) 1.42
Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. Int J Cancer (1998) 1.41
Surveillance of heterosexually acquired HIV infection and AIDS. Lancet (1995) 1.40
[Survey on cases of primary tuberculosis in the department of Gironde]. Rev Mal Respir (1999) 1.38
Hospital-based surveillance and emerging patterns of HIV transmission. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA) AIDS (1996) 1.38
Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004. HIV Med (2007) 1.36
Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997. Am J Epidemiol (2001) 1.35
Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay. AIDS (2001) 1.34
Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda. Pediatrics (1993) 1.33
Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002. HIV Med (2005) 1.32
Should screening of genital infections be part of antenatal care in areas of high HIV prevalence? A prospective cohort study from Kigali, Rwanda, 1992-1993. The Pregnancy and HIV (EGE) Group. Genitourin Med (1995) 1.31
Improved knowledge and practices among end-users of mother-to-child transmission of HIV prevention services in rural Zimbabwe. Trop Med Int Health (2006) 1.30
Seroincidence of HIV-1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988-1992. AIDS (1994) 1.28
Perinatal transmission of HIV-1: lack of impact of maternal HIV infection on characteristics of livebirths and on neonatal mortality in Kigali, Rwanda. AIDS (1991) 1.27
Urease-positive thermophilic Campylobacter (Campylobacter laridis variant) isolated from an appendix and from human feces. J Clin Microbiol (1988) 1.20
Prioritising prevention strategies for patients in antiretroviral treatment programmes in resource-limited settings. AIDS Care (2010) 1.19
Estimation of HIV-1 prevalence in the population of Abidjan by adjustment of the prevalence observed in antenatal centres. AIDS (1999) 1.19
Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993. Pediatr Infect Dis J (1996) 1.19
Determinants of delayed diagnosis of HIV infection in France, 1993-1995. AIDS (1998) 1.18
HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002. Int J Tuberc Lung Dis (2006) 1.18
Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997. J Am Coll Nutr (2001) 1.18
Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection. The Groupe d'Epidémiologie Clinique Du SIDA en Aquitaine. Obstet Gynecol (1995) 1.17
Anaemia during pregnancy in Burkina Faso, west Africa, 1995-96: prevalence and associated factors. DITRAME Study Group. Bull World Health Organ (1999) 1.16
Comparison of different tests for Campylobacter pylori. Scand J Gastroenterol Suppl (1988) 1.16
Cervical dysplasia and HIV type 1 infection in African pregnant women: a cross sectional study, Kigali, Rwanda. The Pregnancy and HIV Study Group (EGE). Sex Transm Infect (1999) 1.15
Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients. HIV Med (2005) 1.15
[The Ditrame (ANRS 049) clinical trial aimed at reducing the mother-child transmission of HIV in Abidjan. Participants' understanding of the trial principles]. Presse Med (2003) 1.14
Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke. J Infect Dis (2012) 1.13
Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. HIV Med (2004) 1.13
Prevalence of coeliac disease in diabetic children and their first- degree relatives in west Algeria: screening with serological markers. Acta Paediatr Suppl (1996) 1.13
Progression of human immunodeficiency virus infection in patients with tuberculosis disease. A cohort study in Bordeaux, France, 1988-1994. The Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA). Am J Epidemiol (1997) 1.13
Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Dyscer-CI Group. Cancer (1998) 1.11
Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine. Clin Infect Dis (2000) 1.09
Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Côte d'Ivoire, West Africa. J Acquir Immune Defic Syndr (2003) 1.09
Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France. HIV Med (2009) 1.08
Low birthweight in infants born to African HIV-infected women: relationship with maternal body weight during pregnancy: Pregnancy and HIV Study Group (EGE). J Trop Pediatr (1999) 1.03
Zidovudine to decrease mother-to-child transmission of HIV-1: is it good for developing countries? AIDS (1995) 1.03
An assessment of the understanding of the offer of routine HIV testing among pregnant women in rural Zimbabwe. AIDS Care (2008) 1.03
[Factors related to length of hospitalization of elderly patients during short stay]. Rev Epidemiol Sante Publique (1987) 1.02
Mother-to-infant transmission of human immunodeficiency virus by breast milk: presumed innocent or presumed guilty? Clin Infect Dis (1992) 1.02
Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998. J Acquir Immune Defic Syndr (2001) 1.01
Care of human immunodeficiency virus-infected children in developing countries. International Working Group on Mother-to-Child Transmission of HIV. Pediatr Infect Dis J (1998) 1.01
[Attitudes and behavior of pregnant women towards HIV screening in Abidjan (Ivory Coast) in 1995 and 1996]. Sante (1998) 1.00
[HBs antigen carrier state in pregnant women in Bobo Dioulasso (Burkina Faso)]. Dakar Med (2000) 0.99
Evaluation and simplification of the World Health Organization clinical case definition for paediatric AIDS. AIDS (1989) 0.99
[Time trends in demographic and clinical characteristics of adult patients on HAART initiation in West Africa]. Med Mal Infect (2009) 0.99
[Laryngeal tuberculosis: apropos of 15 cases]. Rev Laryngol Otol Rhinol (Bord) (2001) 0.98
Prevention of mother-to-child transmission of HIV in Africa: uptake of pregnant women in a clinical trial in Abidjan, Côte d'Ivoire. AIDS (1998) 0.98
[Cysticercosis and neurocysticercosis: epidemiological survey in North Togo]. Bull Soc Pathol Exot (1990) 0.98
Safety and immunogenicity of high-dose Edmonston-Zagreb measles vaccine in children with HIV-1 infection. A cohort study in Kigali, Rwanda. Am J Dis Child (1992) 0.97
15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery. Sex Transm Infect (2002) 0.95
Telematics: a new tool for epidemiological surveillance of diarrhoeal diseases in the Aquitaine sentinel network. BMJ (1990) 0.95
HIV infection among pregnant women in Bobo-Dioulasso, Burkina Faso: comparison of voluntary and blinded seroprevalence estimates. Int J STD AIDS (1999) 0.95
Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries. Int J Tuberc Lung Dis (2009) 0.95
Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype. Aliment Pharmacol Ther (2007) 0.95
Community-based assessment of infant feeding practices within a programme for prevention of mother-to-child HIV transmission in rural Zimbabwe. Public Health Nutr (2006) 0.94
[Human immunodeficiency virus infection and AIDS in Aquitaine. 10 years' experience of a hospital information system, 1985-1995. Le Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA)]. Presse Med (1997) 0.94
HIV prevention in Latin America: reaching youth in Colombia. AIDS Care (2003) 0.94
Determinants of response to first HAART regimen in antiretroviral-naïve patients with an estimated time since HIV seroconversion. HIV Med (2006) 0.94
Seroprevalence of syphilis among women attending urban antenatal clinics in Burkina Faso, 1995-8. The DITRAME Study Group. DIminunation de la TRAnsmission Mère-Enfant. Sex Transm Infect (2000) 0.93
Evaluation of 2 techniques of HIV pre-test counselling for pregnant women in west Africa. DITRAME Study Group. Int J STD AIDS (1999) 0.93
Increases in CD3+CD4-CD8- T lymphocytes in AIDS patients with disseminated Mycobacterium avium-intracellulare complex infection. J Infect Dis (1996) 0.92
Macromolecular transport in jejunal mucosa of children with severe malnutrition: a quantitative study. J Pediatr Gastroenterol Nutr (1984) 0.92
Effect of feeding yogurt versus milk in children with acute diarrhea and carbohydrate malabsorption. J Pediatr Gastroenterol Nutr (2001) 0.92
Herpes zoster and human immunodeficiency virus infection: a cohort study of 101 coinfected patients. Groupe d'Epidémiologie clinique du SIDA en aquitaine. J Infect Dis (1993) 0.90
Transient seroreversion in children born to human immunodeficiency virus 1-infected mothers. Pediatr Infect Dis J (1992) 0.90
Rapid change in the use of antiretroviral agents and improvement in a population of HIV-infected patients: France, 1995-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA). J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.89
Serum triglycerides, HIV infection, and highly active antiretroviral therapy, Aquitaine Cohort, France, 1996 to 1998. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA). J Acquir Immune Defic Syndr (2000) 0.89